Fleury S.A. (FLRY3.SA)
- Previous Close
14.31 - Open
14.46 - Bid 14.46 x --
- Ask 14.48 x --
- Day's Range
14.37 - 14.56 - 52 Week Range
13.69 - 18.96 - Volume
2,937,000 - Avg. Volume
3,065,154 - Market Cap (intraday)
7.911B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
15.76 - EPS (TTM)
0.92 - Earnings Date Aug 8, 2024
- Forward Dividend & Yield 0.15 (1.03%)
- Ex-Dividend Date Mar 20, 2024
- 1y Target Est
19.63
Fleury S.A., together with its subsidiaries, provides medical services in the diagnostic, treatment, clinical analysis, health management, medical care, orthopedics, and ophthalmology areas in Brazil. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It provides laboratory and imaging tests, genomics, health management and platform, diagnostic information, check-up and reference laboratory, clinic day, infusion center, orthopedics and ophthalmology, dental imaging tests, and diagnostic imaging services. The company also offers Saúde I, a digital healthcare platform that provides services, including scheduling and performing teleconsultations, and face-to-face consultations, as well as scheduling and accessing diagnostic test results, electronic medical record, and self-manage health issues. It operates customer service units and hospital-based units under the Fleury, Felippe Mattoso, Labs a+, Diagnoson a+, Papaiz, Serdil, LAFE, Instituto de Radiologia de Natal, Centro de Patologia Clínica, Diagmax, Santécorp, a+SP, CIP, Saha, Moacir Cunha, Vita, e Campana, Methodos, Pretti, Bioclinico, a+PE, Marcelo Magalhaes, Inlab, Weinmann, a+, a+BA, IRN, CPC, and a+PI brand names. The company was founded in 1926 and is headquartered in São Paulo, Brazil.
ri.fleury.com.br27,300
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: FLRY3.SA
Performance Overview: FLRY3.SA
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FLRY3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FLRY3.SA
Valuation Measures
Market Cap
7.81B
Enterprise Value
11.13B
Trailing P/E
15.48
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.06
Price/Book (mrq)
1.51
Enterprise Value/Revenue
1.56
Enterprise Value/EBITDA
6.06
Financial Highlights
Profitability and Income Statement
Profit Margin
6.97%
Return on Assets (ttm)
6.68%
Return on Equity (ttm)
12.35%
Revenue (ttm)
7.14B
Net Income Avi to Common (ttm)
497.86M
Diluted EPS (ttm)
0.92
Balance Sheet and Cash Flow
Total Cash (mrq)
889.53M
Total Debt/Equity (mrq)
80.74%
Levered Free Cash Flow (ttm)
298.96M